Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) — The “Cancer Diagnostics Market – Technologies, Applications and End-Use Facilities” has been added to ResearchAndMarkets.com’s offering.
The cutting-edge landscape of cancer diagnostics employs advanced technologies that enhance early intervention, precise staging, and tailored treatment plans. This domain sees the implementation of techniques like biomarker identification, genetic mutation detection, and sophisticated modalities such as in vitro diagnostics (IVD), CT, MRI, PET, and ultrasound imaging. Biopsies remain a cornerstone, while AI-imaging, next-generation sequencing, liquid biopsy, and genomic testing exemplify the technology-driven accuracy and minimized invasiveness promoting personalized medicine.
Globally, the cancer diagnostics market is valued at US$95.3 billion and is expected to surge to US$153 billion by 2032 at a 7% CAGR. This expansion is propelled by increasing cancer rates due to demographic shifts and lifestyle changes necessitating early detection. Governmental and healthcare initiatives toward boosting diagnostic infrastructure and awareness programs further fuel market growth. Precision medicine has heightened the demand for molecular tests, with nano-tech and AI paving the way for improved diagnostic sensitivity and interpretation, fostering innovative collaborations to meet global demand effectively.
Cancer Diagnostics Regional Market Analysis
North America is poised at the forefront with a 39.8% market share by 2025, driven by advanced healthcare, significant R&D investments, and the early adoption of AI and liquid biopsy technologies. Strategic government policies, reimbursement frameworks, and a robust market player presence solidify its leadership. The region’s prominence, particularly in the U.S., is attributed to high screening rates and comprehensive research networks. Contrastingly, Asia-Pacific is predicted to register the fastest growth at a 7.9% CAGR, powered by burgeoning healthcare delivery systems and cancer awareness in countries like China, India, and Japan.
Cancer Diagnostics Market Analysis by Technology
Dominant in the technology sector by 2025, IVD testing is valued for accuracy and early detection, notably for prevalent cancers like breast and lung cancers. IVD advancements in PCR, NGS, immunoassays, and liquid biopsy have enhanced diagnostic performance. Automated systems heighten efficiency in medical settings. Concomitantly, Laboratory Developed Tests (LDTs) are set for a rapid 9% CAGR growth due to their vital role in personalized medicine, allowing for rapid assay customization for rare cancers, significantly elevating precision oncology through new clinical insight integration.
Cancer Diagnostics Market Analysis by Application
The breast cancer segment emerges as the largest in diagnostics by application for 2025, with an emphasis on early detection and personalized care driven by global prevalence and awareness. Techniques like mammography and MRI, alongside innovations in 3D imaging and AI, enhance diagnostic precision. Meanwhile, colorectal cancer diagnostics are poised for an 8.3% CAGR, amid rising disease incidences and the expansion of non-invasive screening assays, fueled by supportive policies and research advancements.
Cancer Diagnostics Market Analysis by End User
Hospitals, encompassing 49% of the market share by 2025, benefit from superior infrastructure and cross-disciplinary competencies, spearheading comprehensive diagnostics from biopsy to molecular tests. Investment in next-generation sequencing and digital pathology secures their standing. Diagnostic labs are expected to grow at a 7.6% CAGR, supported by the demand for high-volume, accurate testing and technology-driven advancements. Imaging centers specializing in MRI, CT, and PET scans emerge as crucial players in early cancer detection and ongoing research driven diagnostic ventures inject momentum into these sectors.
Cancer Diagnostics Market Report Scope
- Analysis Period: 2022-2032
- Base Year: 2025
- Forecast Period: 2025-2032
- Units: Value market in US$
- Companies Mentioned: 15+
- Abbott Laboratories, Inc.
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- GE Healthcare
- Hologic Inc.
- Illumina, Inc.
- Koninklijke Philips N.V.
- Myriad Genetics, Inc.
- QIAGEN N.V.
- Siemens Healthineers
- Thermo Fisher Scientific, Inc.
Cancer Diagnostics Market by Geographic Region
- North America (The United States, Canada, and Mexico)
- Europe (Germany, France, the United Kingdom, Italy, Spain, and Rest of Europe)
- Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, and Rest of South America)
- Rest of World
Cancer Diagnostics Market by Technology
- In Vitro Diagnostics (IVD)
- Diagnostic Imaging
- Tumor Biomarker Tests
- Biopsy Techniques
- Laboratory-Developed Tests (LDTs)
- Other Technologies (Liquid Biopsy, Genetic/Genomic Testing, and other Emerging Technologies)
Cancer Diagnostics Market by Application
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Liver Cancer
- Blood Cancer
- Kidney Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Melanoma
- Others (Including Head & Neck, Bladder, Brain/CNS, Gastric/Stomach, Thyroid, Cervical, Uterine/Endometrial, Esophageal, Gallbladder, and rare cancers)
Cancer Diagnostics Market by End User
- Hospitals
- Diagnostic Laboratories
- Academic & Research Institutes
- Other End Users (Including Specialty Clinics, Diagnostic Imaging Centers, Point-of-Care/Ambulatory Centers, and others)
Key Attributes
| Report Attribute | Details |
| No. of Pages | 278 |
| Forecast Period | 2025-2032 |
| Estimated Market Value (USD) in 2025 | $95.3 Billion |
| Forecasted Market Value (USD) by 2032 | $153 Billion |
| Compound Annual Growth Rate | 7% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/5r0pv7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Cancer Diagnostics Market
